SI3193923T1 - Adjuvansi - Google Patents

Adjuvansi

Info

Publication number
SI3193923T1
SI3193923T1 SI201531005T SI201531005T SI3193923T1 SI 3193923 T1 SI3193923 T1 SI 3193923T1 SI 201531005 T SI201531005 T SI 201531005T SI 201531005 T SI201531005 T SI 201531005T SI 3193923 T1 SI3193923 T1 SI 3193923T1
Authority
SI
Slovenia
Prior art keywords
adjuvants
Prior art date
Application number
SI201531005T
Other languages
English (en)
Inventor
Lucas A. Th. HILGERS
Peter Paul L. I. PLATENBURG
DEN BOSCH Johannes F. VAN
Original Assignee
Litevax B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litevax B.V. filed Critical Litevax B.V.
Publication of SI3193923T1 publication Critical patent/SI3193923T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201531005T 2014-07-24 2015-07-24 Adjuvansi SI3193923T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2013257 2014-07-24
EP15751144.5A EP3193923B1 (en) 2014-07-24 2015-07-24 Adjuvants
PCT/NL2015/050544 WO2016013938A1 (en) 2014-07-24 2015-07-24 Adjuvants

Publications (1)

Publication Number Publication Date
SI3193923T1 true SI3193923T1 (sl) 2020-02-28

Family

ID=52014300

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531005T SI3193923T1 (sl) 2014-07-24 2015-07-24 Adjuvansi

Country Status (18)

Country Link
US (1) US10342867B2 (sl)
EP (1) EP3193923B1 (sl)
JP (1) JP6765371B2 (sl)
KR (1) KR102458982B1 (sl)
CN (1) CN106573047B (sl)
AU (1) AU2015294769B2 (sl)
BR (1) BR112017001121B1 (sl)
CA (1) CA2954043A1 (sl)
DK (1) DK3193923T3 (sl)
ES (1) ES2759542T3 (sl)
HR (1) HRP20192113T1 (sl)
HU (1) HUE047467T2 (sl)
LT (1) LT3193923T (sl)
NZ (1) NZ728551A (sl)
PL (1) PL3193923T3 (sl)
PT (1) PT3193923T (sl)
SI (1) SI3193923T1 (sl)
WO (1) WO2016013938A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024083912A1 (en) 2022-10-19 2024-04-25 Glyprovac Aps Glycosylated yghj polypeptides from uropathogenic e. coli

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5600330A (en) 1994-07-12 1997-02-04 Ascension Technology Corporation Device for measuring position and orientation using non-dipole magnet IC fields
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
WO2001024784A2 (en) 1999-10-04 2001-04-12 Fujisawa Pharmaceutical Co., Ltd. New use
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
MXPA99011191A (es) 1999-12-03 2005-04-04 Univ Mexico Nacional Autonoma Inmunogeno, anti-veneno y vacuna contra el venenode la arana viuda negra.
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
JP5564672B2 (ja) 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
JP4674696B2 (ja) 2007-04-03 2011-04-20 日本特殊陶業株式会社 スパークプラグの製造方法
EP2397484A1 (en) 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
NZ728551A (en) 2023-02-24
AU2015294769B2 (en) 2020-07-16
EP3193923A1 (en) 2017-07-26
BR112017001121A2 (pt) 2018-01-23
CN106573047B (zh) 2021-10-12
JP6765371B2 (ja) 2020-10-07
BR112017001121B1 (pt) 2023-11-07
LT3193923T (lt) 2019-12-10
KR20170040196A (ko) 2017-04-12
AU2015294769A1 (en) 2017-01-19
JP2017522391A (ja) 2017-08-10
CN106573047A (zh) 2017-04-19
KR102458982B1 (ko) 2022-10-26
HUE047467T2 (hu) 2020-04-28
EP3193923B1 (en) 2019-09-18
HRP20192113T1 (hr) 2020-02-21
ES2759542T3 (es) 2020-05-11
PL3193923T3 (pl) 2020-03-31
US10342867B2 (en) 2019-07-09
PT3193923T (pt) 2019-12-05
DK3193923T3 (da) 2019-12-09
US20170209568A1 (en) 2017-07-27
WO2016013938A1 (en) 2016-01-28
CA2954043A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
AU361515S (en) Dishrack
GB201410971D0 (en) Vaccine
AU362944S (en) Lapboard
PL3185899T3 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
DK3178931T3 (en) Anti-orai1-antistof
DK3002465T3 (en) Hydrauliksystem
IL267264A (en) Auxiliary substances
HUE053284T2 (hu) Vakcina
GB201621375D0 (en) Adjuvants
GB201618479D0 (en) Adjuvants
PT3193923T (pt) Adjuvantes
DK3145380T3 (en) Toiletventilationssystem
GB2522661B (en) Context configuration
GB201417214D0 (en) Vaccine
AU5594P (en) Lanoregon Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5288P (en) FLOMANTOG Mandevilla sanderi
AU5287P (en) FLOMANPIW Mandevilla sanderi